Establishes office hours as 8:00 a.m. to 5:00 p.m.
Use of Agency Property
Establishes $0.25/page reproduction cost and restrictions on the use of Agency property.
Request to View Public Records
Provides information by which public records can be obtained; shows the cost and formats which can be used to provide the records.
Investigation of Excessive Exposure In X-ray Departments
Establishes a model program for investigating overexposures in x-ray departments.
Occupational Radiation Exposure Records System
Establishes a model program for preparation, retention and reporting of records of occupational radiation exposures.
Operating Philosophy for Maintaining Occupational Radiation Exposures As Low As Reasonably Achievable
Describes a general operating philosophy acceptable to ARRA as a necessary basis for a program to maintain occupational radiation exposure as low as reasonably achievable.
Monitoring Criteria and Methods to Calculate Occupational Radiation Doses
Provides criteria acceptable to ARRA that may be used by the regulated committee to determine when monitoring is required; describes methods acceptable to ARRA for calculating occupational doses when the intake is known.
Planned Special Exposures
Provides guidance on conditions and prerequisites for permitting planned special exposures, the associated specific monitoring and reporting requirements, and examples of acceptable means for satisfying these requirements.
ALARA Levels for Exposures and Effluents from Radiation Sources
Provides information on designing an acceptable ALARA program.
Acceptable Reporting of Laboratory Data for Ionizing Radiation
Outlines lab data reporting and quality control criteria to provide for a consistent and scientifically defensible basis for Agency decisions.
Bioassay Requirements for Medical Users
Allows infrequent users of iodine 125 and iodine 131 up to 10 days post use to obtain a bioassay without penalty.
Termination/Closeout of Licensee Programs
Establishes the manner in which licensees requesting termination or closeout will have their facility evaluated for release.
Biohazardous Radioactive Waste
Releases exempt quantities of nuclear medicine waste to the jurisdiction of ADEQ.
Radiopharmaceuticals for Human Use
Grants New Drug Application equivalency to biological products which have received a Product License Approval.